(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Abou-Nassar KE, Stevenson KE, Antin JH, McDermott K, Ho VT, Cutler CS, LaCasce AS, Jacobsen ED, Fisher DC, Soiffer RJ, Alyea EP, Koreth J, Freedman AS.
Abou-Nassar KE, et al. Among authors: jacobsen ed.
Bone Marrow Transplant. 2011 Dec;46(12):1503-9. doi: 10.1038/bmt.2010.339. Epub 2011 Jan 24.
Bone Marrow Transplant. 2011.
PMID: 21258420
Free PMC article.
Clinical Trial.